rs758239066
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_000548.5(TSC2):c.17G>A(p.Ser6Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000548.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250972Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135848
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461656Hom.: 0 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 727116
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74490
ClinVar
Submissions by phenotype
Tuberous sclerosis 2 Uncertain:1Benign:2
- -
- -
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.S6N variant (also known as c.17G>A), located in coding exon 1 of the TSC2 gene, results from a G to A substitution at nucleotide position 17. The serine at codon 6 is replaced by asparagine, an amino acid with highly similar properties. This alteration has been reported in an individual with autism spectrum disorder (Bahl S et al. Mol Autism, 2013 Mar;4:5). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at